Home › Funds › Royce & Associates › LAB
Royce & Associates position in LAB
STANDARD BIOTOOLS INC · Industrials
Latest position (Q2 2026)4.53M sh
Reported value held$3.72M
Portfolio Weight0.03%
First reportedQ2 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 304.23K | $538.49K | New |
| Q3 2024 | 614.55K | $1.19M | Add |
| Q4 2024 | 1.46M | $2.55M | Add |
| Q1 2025 | 2.00M | $2.16M | Add |
| Q2 2025 | 2.64M | $3.16M | Add |
| Q3 2025 | 2.80M | $3.65M | Add |
| Q4 2025 | 2.89M | $3.69M | Add |
| Q1 2026 | 3.01M | $2.76M | Add |
| Q2 2026 | 4.53M | $3.72M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding LAB
- Casdin Capital 88.78M sh · $73.04M · Q2 2026
- Viking Global Investors 58.65M sh · $48.25M · Q2 2026
- Vanguard Group 17.30M sh · $22.14M · Q4 2025
- BlackRock Inc 8.25M sh · $6.79M · Q2 2026
- Geode Capital Management 3.90M sh · $3.21M · Q2 2026
- Millennium Management 3.51M sh · $2.89M · Q2 2026
- Morgan Stanley 2.83M sh · $2.33M · Q2 2026
- D. E. Shaw & Co 2.82M sh · $2.32M · Q2 2026
- Citadel Advisors 2.38M sh · $1.96M · Q2 2026
- Arrowstreet Capital 1.99M sh · $1.64M · Q2 2026
- Charles Schwab Investment Management 1.76M sh · $1.45M · Q2 2026